Research Article

Neonatal Screening for Sickle Cell Disease in Congo

Table 3

Prevalence of sickle cell disease among newborns according to the departments of Congo between November 2019 and March 2020.

DepartmentTotal, n (%)Carrier Hb AA, n (%)Carrier Hb AS/AC, n (%)MSS, n (%)

Bouendza113 (3.90)98 (86.7)13 (11.5)2 (1.77)
Brazzaville1560 (53.8)1241 (79.6)298 (19.1)21 (1.35)
Cuvette Centrale124 (4.28)92 (74.2)32 (25.8)
Cuvette-Ouest78 (2.69)60 (76.9)16 (20.5)2 (2.56)
Kouilou38 (1.31)34 (89.5)4 (10.5)
Lekoumou54 (1.86)42 (77.8)12 (22.2)
Likouala60 (2.07)54 (90.0)6 (10.0)
Niari179 (6.18)133 (74.3)44 (24.6)2 (1.12)
Plateau121 (4.18)98 (81.0)22 (18.2)1 (0.83)
Pointe Noire370 (12.8)280 (75.7)81 (21.9)9 (2.43)
Pool132 (4.56)101 (76.5)29 (22.0)2 (1.52)
Sangha68 (2.35)62 (91.2)6 (8.82)
Total2897 (100)2295 (79.21)563 (19.43)39 (1.35)

MSS: major sickle cell syndrome (FS, FSE, and FSA).